ArticleSignal transduction and targeted therapy2022

Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis.

Jin-Fei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.